| Financial Year |
March 31 2023 |
| Monetary Funds |
640,722,960.58 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,192,845,895.73 |
| Accounts Receivable |
119,947,042.00 |
| Advances to Suppliers |
212,382.56 |
| Other Receivables |
1,297,301.65 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
486,462,585.79 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
67,774,355.40 |
| Total Current Assets |
2,781,604,699.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,167,094,178.21 |
| Under-construction Projects |
234,825,608.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
182,454,128.92 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
86,007,103.74 |
| Sub-Total of Non-Current Assets |
3,933,797,641.39 |
| Total Assets |
6,715,402,341.18 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
950,889,095.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
31,331,810.38 |
| Taxes Payable |
2,363,960.53 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
13,733,336.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
759,997.61 |
| Other Current Liabilities |
446,951,803.91 |
| Sub-Total of Current Liabilities |
1,486,499,166.59 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
47,171,931.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
57,738,372.59 |
| Total Liabilities |
1,544,237,539.18 |
| Paid-In Capital(Or Share Stock) |
1,200,000,000.00 |
| Capital Surplus |
2,107,126,814.56 |
| Surplus Reserve |
316,209,243.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,437,318,718.39 |
| Minority Stockholder's Interest |
3,300,343.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,167,864,458.75 |
| Owner's Equity（Stockholder's Equity） |
5,171,164,802.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,715,402,341.18 |
